Mr Kevin Peters, FNP | |
444 N Eola Rd Ste 110, Aurora, IL 60502-9619 | |
(630) 692-5660 | |
(630) 692-5661 |
Full Name | Mr Kevin Peters |
---|---|
Gender | Male |
Speciality | Nurse Practitioner |
Experience | 8 Years |
Location | 444 N Eola Rd Ste 110, Aurora, Illinois |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083123038 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | 277000991 (Illinois) | Secondary |
363L00000X | Nurse Practitioner | 2770000991 (Illinois) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Copley Memorial Hospital | Aurora, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Rush-copley Medical Group Nfp | 7618864877 | 108 |
News Archive
A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI's National Clinical Trials Network (NCTN), were associated with clinical care guidelines or new drug approvals. NCI is part of the National Institutes of Health.
Boehringer Ingelheim's novel oral anticoagulant dabigatran etexilate, received a positive opinion from the European Medicines Agency's medicinal committee today.
Since mice share 90 percent of our genes they play an important role in understanding human genetics. The European Mouse Disease Clinic brought together scientists from across Europe to investigate the functions of 320 genes in mice. Over half of these genes had no previously known role, and the remaining genes were poorly understood.
QLT Inc. today announced results from a Phase II proof-of-concept clinical trial for the olopatadine punctal plug delivery system (O‑PPDS).
› Verified 5 days ago
Entity Name | Rush-copley Medical Group Nfp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093075848 PECOS PAC ID: 7618864877 Enrollment ID: O20040310001029 |
News Archive
A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI's National Clinical Trials Network (NCTN), were associated with clinical care guidelines or new drug approvals. NCI is part of the National Institutes of Health.
Boehringer Ingelheim's novel oral anticoagulant dabigatran etexilate, received a positive opinion from the European Medicines Agency's medicinal committee today.
Since mice share 90 percent of our genes they play an important role in understanding human genetics. The European Mouse Disease Clinic brought together scientists from across Europe to investigate the functions of 320 genes in mice. Over half of these genes had no previously known role, and the remaining genes were poorly understood.
QLT Inc. today announced results from a Phase II proof-of-concept clinical trial for the olopatadine punctal plug delivery system (O‑PPDS).
› Verified 5 days ago
Entity Name | E Mediate Cure Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780051466 PECOS PAC ID: 4587974332 Enrollment ID: O20151105002342 |
News Archive
A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI's National Clinical Trials Network (NCTN), were associated with clinical care guidelines or new drug approvals. NCI is part of the National Institutes of Health.
Boehringer Ingelheim's novel oral anticoagulant dabigatran etexilate, received a positive opinion from the European Medicines Agency's medicinal committee today.
Since mice share 90 percent of our genes they play an important role in understanding human genetics. The European Mouse Disease Clinic brought together scientists from across Europe to investigate the functions of 320 genes in mice. Over half of these genes had no previously known role, and the remaining genes were poorly understood.
QLT Inc. today announced results from a Phase II proof-of-concept clinical trial for the olopatadine punctal plug delivery system (O‑PPDS).
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Kevin Peters, FNP 444 N Eola Rd Ste 110, Aurora, IL 60502-9619 Ph: (630) 692-5660 | Mr Kevin Peters, FNP 444 N Eola Rd Ste 110, Aurora, IL 60502-9619 Ph: (630) 692-5660 |
News Archive
A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI's National Clinical Trials Network (NCTN), were associated with clinical care guidelines or new drug approvals. NCI is part of the National Institutes of Health.
Boehringer Ingelheim's novel oral anticoagulant dabigatran etexilate, received a positive opinion from the European Medicines Agency's medicinal committee today.
Since mice share 90 percent of our genes they play an important role in understanding human genetics. The European Mouse Disease Clinic brought together scientists from across Europe to investigate the functions of 320 genes in mice. Over half of these genes had no previously known role, and the remaining genes were poorly understood.
QLT Inc. today announced results from a Phase II proof-of-concept clinical trial for the olopatadine punctal plug delivery system (O‑PPDS).
› Verified 5 days ago
Courtney Harley, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2720 E New York St, Ste 108, Aurora, IL 60502 Phone: 630-820-7045 Fax: 630-820-7047 | |
Tochi Okwueze, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 400 N Highland Ave, Aurora, IL 60506 Phone: 630-978-2532 | |
Heidijo Elyea, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1256 Waterford Drive, Suite 120, Aurora, IL 60504 Phone: 630-499-6688 Fax: 630-499-6689 | |
Mrs. Haley S.v. Murphy, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 N Highland Ave, Aurora, IL 60506 Phone: 630-892-4355 | |
Ms. Carole Wolfson, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 581 Sullivan Rd Ste B, Aurora, IL 60506 Phone: 630-859-3877 Fax: 630-859-8920 | |
Ms. Kenisha Francisco, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 N Highland Ave, Aurora, IL 60506 Phone: 630-978-2532 | |
Terra L Kolacki, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 444 N Eola Rd Ste 110, Aurora, IL 60502 Phone: 630-692-5660 Fax: 630-692-5661 |